Latest filing published 15 Jun 2022 for BioRestorative Therapies, Inc., €670.
Filing timeline
BuySaleInsider track record
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Robert Eugene Kristal: trading record in brief
Robert Eugene Kristal (finance chief) discloses dealings in BioRestorative Therapies, Inc. to SEC (Form 4). The record holds 3 filings, for trades running from 8 April 2022 to 15 June 2022.
Every open-market trade on record is a purchase: 3 purchases worth €41k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
Half of the purchases are above €852 and half below. Clusters matter here: 3 out of 3 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
On 15 June 2022 came the latest disclosure, an open-market purchase for €670 in BioRestorative Therapies, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robert Eugene Kristal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 194 shares@ US$3.611.6% of flowCommon StockSEC:0001567619-22-012912:0Canonical exit: 13 Sept 2022 (T+90)
- 200 shares@ US$4.562.1% of flowCommon StockSEC:0001567619-22-012416:0Canonical exit: 5 Sept 2022 (T+90)
- 7,600 shares@ US$5.7196.3% of flowCommon StockSEC:0001567619-22-008332:0Canonical exit: 7 Jul 2022 (T+90)
3 of 3 declarations